-
A Peek Into The Market Before The Trading Starts
Wednesday, May 11, 2011 - 7:42am | 378Pre-open movers US stock futures are slightly higher this morning. Gold and silver futures continued to recover from the last week's losses. Futures on the Dow Jones Industrial Average gained 19 points to 12,719.00 and futures on the S&P 500 stock index rose 1.70 points to 1,355.50. Nasdaq 100...
-
Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze
Wednesday, May 11, 2011 - 7:29am | 148Halozyme Therapeutics, Inc. (Nasdaq: HALO) and ViroPharma Incorporated (Nasdaq: VPHM), today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 in the development of a subcutaneous formulation of Cinryze. Under terms of the agreement, Halozyme may receive...
-
US Stock Futures Up As Investors Await Macy's Earnings; Gold, Silver Futures Rise
Wednesday, May 11, 2011 - 6:34am | 476US stock futures are higher this morning. Gold and silver futures continued to recover from the last week's losses. Futures on the Dow Jones Industrial Average gained 32 points to 12,732.00 and futures on the S&P 500 stock index rose 3.30 points to 1,357.10. Nasdaq 100 futures surged 3.50...
-
Goldman Sachs Upgrades Johnson & Johnson To Buy, Raises PT To $77
Wednesday, May 11, 2011 - 5:56am | 28Goldman Sachs has upgraded Johnson & Johnson (NYSE: JNJ) from Neutral to buy and has raised the price target from $64 to $77.
-
Goldman Sachs Downgrades Bristol-Myers Squibb To Neutral, $32 PT
Wednesday, May 11, 2011 - 5:54am | 25Goldman Sachs has downgraded Bristol-Myers Squibb (NYSE: BMY) from Buy to Neutral and maintains its $32 price target.
-
TEVA Reports 6.7% Rise In Q1 Net Income
Wednesday, May 11, 2011 - 4:06am | 144Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) reported a 6.7% rise in its first-quarter net income. The company also affirmed its projections for the full year. The company's profit increased to $761 million, or $0.84 per share, versus $713 million, or $0.79 per share, in the year-ago period...
-
Earnings Scheduled For May 11 (TM, MT, TEVA, ZIP, M, BAM, CSCO, IAG, SYMC, ACXM, SSRX, SVN, APAC, CONM)
Wednesday, May 11, 2011 - 2:20am | 375Toyota Motor Corp (NYSE: TM) is estimated to post its FQ3 EPS at $0.64 on revenue of $63.42 billion. Arcelor Mittal (NYSE: MT) is expected to post its Q1 earnings at $0.48 per share on revenue of $22.03 billion. Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) is projected to post its Q1...
-
Short-Term Action Broke Through Resistance 05-10-2011
Tuesday, May 10, 2011 - 7:21pm | 897Cusick's Corner The mood in the market is more upbeat. Short-term market action broke through resistance of 1350 on the June S&P500 future which means that this move to the upside might have a fighting chance. Small Cap and Mid Cap stocks have been leading this market's move higher. Most...
-
Hi-Tech Pharmacal Divests its Midlothian Laboratories Division (HITK)
Tuesday, May 10, 2011 - 5:03pm | 81Hi-Tech Pharmacal Co. (NASDAQ: HITK), a specialty pharmaceuticals company, announced today that it has divested the Midlothian Laboratories division in exchange for a cash payment. Hi-Tech retained marketing and distribution rights to generic buprenorphine sublingual tablets, an ANDA that is filed...
-
Using the Euro as a Barometer 05-10-2011
Tuesday, May 10, 2011 - 4:03pm | 1002Cusick's Corner The market bounced this morning after a brief breach of support, 1340 level for the June S&P and 134 level for the SPY; back up on a weak Buck and the promise of continual economic growth. The short-term market action needs to break current resistance, 1350 on the June future,...
-
Earnings Preview: Teva Pharmaceutical Industries (TEVA)
Tuesday, May 10, 2011 - 3:00pm | 143Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) is set to report earnings tonight, and Wall Street will be looking forward to hearing how the generic drug industry is going, especially in light of the biggest selling drug of all time, Lipitor, going generic next year. At last check, shares were...
-
Perrigo Announces Settlement of Cutivate Lotion Litigation
Tuesday, May 10, 2011 - 11:32am | 104Perrigo Company (Nasdaq: PRGO) today announced that it has agreed to settle all Hatch-Waxman litigation relating to fluticasone lotion brought by Nycomed US Inc. by taking a license under all relevant patents. Under the terms of the settlement, Perrigo can launch a generic version of Cutivate®...
-
Market Analysts coverage on 5/10/11- NRG, OLP, RIO, TAL, TRGP, VIVO, VRX, VVC, AAUKY, BHP, BOBE, CEPH, CSCO, CZZ, GPK, MDVN, NGLS, NNA
Tuesday, May 10, 2011 - 10:14am | 1311Dahlman Rose analysts initiated coverage on shares of NRG Energy Inc. (NRG),a wholesale power generation company. They set a “buy” rating and a $29.00 price target on the stock. Compass Point analysts initiated coverage on shares of a self-administered and self-managed real estate investment...
-
Morning Market Losers (BMTI, NSPH, HEAT, PAL)
Tuesday, May 10, 2011 - 9:57am | 116BioMimetic Therapeutics Inc (NASDAQ: BMTI) shares dropped 32.86% to $8.99 at 9:55 am. BMTI reported a Q1 net loss of $8.0 million. Nanosphere Inc (NASDAQ: NSPH) dipped 27.99% to $2.11. NSPH priced its underwritten public offering of 13,640,000 shares of its common stock at $2.20 per share....
-
Market updates- BG Group, Celanese, InterContinental Hotels, Imperial Tobacco, Schroders, CE, IHG, IMT, SDR, BG, VRTX, SLXP
Tuesday, May 10, 2011 - 9:11am | 786Celanese Corp (CE), a technology and specialty materials company, raised its 2013 earnings guidance ahead of its investor conference. Celanese Corporation is trading at a price of $33.68 ,a dramatic change of 0.41 with % change of 1.23 from its previous day's close. Currently, the company has a...